(2018). Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients. Egyptian Journal of Pure and Applied Science, 56(2), 17-27. doi: 10.21608/ejaps.2018.181663
MLA
. "Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients". Egyptian Journal of Pure and Applied Science, 56, 2, 2018, 17-27. doi: 10.21608/ejaps.2018.181663
HARVARD
(2018). 'Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients', Egyptian Journal of Pure and Applied Science, 56(2), pp. 17-27. doi: 10.21608/ejaps.2018.181663
VANCOUVER
Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients. Egyptian Journal of Pure and Applied Science, 2018; 56(2): 17-27. doi: 10.21608/ejaps.2018.181663
)
View on SCiNiTO